medigraphic.com
ISSN 1527-3172 (Electronic)

2014, Number 3-4

<< Back Next >>

MEDICC Review 2014; 16 (3-4)

Neurofibromatosis 1 prevalence in children aged 9–11 years, Pinar del Río province, Cuba

Orraca CM, Morejón HG, Cabrera RN, Menéndez GR, Orraca CO

Language: English
References: 22
Page: 22-26
PDF size: 132.98 Kb.


ABSTRACT

Introduction: Neurofibromatosis 1 is one of the most common heritable genetic disorders in humans. It is characterized by formation of neurofibromas, with marked variability in expression. Half the cases are due to autosomal dominant inheritance; the rest arise from de novo mutations. Prevalence varies by population, and prevalence in Cuba is unknown.
Objetive: Determine the prevalence of neurofibromatosis 1 in a population of Cuban children aged 9–11 years old in Pinar del Río Province, Cuba.
Methods: A descriptive cross-sectional study was carried out in Pinar del Río Province in 2004, in which 19,392 children were assessed for neurofibromatosis 1. The study was conducted in two phases: the first, a survey of the entire population aged 9–11 years by genetic counselors in the province's schools; the second, assessment by clinical geneticists of children who met criteria for referral to the Provincial Medical Genetics Center. Neurofibromatosis 1 cases and first-degree relatives were examined to identify the origin of the mutation (de novo or inherited). Neurofibromatosis 1 prevalence was calculated, as well as history of a first-degree relative with the disease and frequency of several principal clinical signs—café au lait spots, freckles in places unexposed to sunlight, presence of neurofibromas, Lisch nodules and characteristic bone lesions.
Results: Of the eligible population, 99.3% was screened (10,034 boys and 9358 girls). Active case finding resulted in referral of 200 children to medical geneticists and the disease was confirmed in 17, for a prevalence of one case per 1141 children aged 9–11 years old. Café au lait spots were the most frequent sign (100%), followed by freckles in areas unexposed to sunlight (82.4%) and characteristic bone lesions (41.2%). Only 4 of the 17 cases were previously being treated for the disease.
Conclusions: Neurofibromatosis 1 has high prevalence in the group studied in Pinar del Rio Province and most cases are not detected in primary health care settings.


REFERENCES

  1. Messiaen L, Vogt J, Bengesser K, Fu C, Mikhail F, Serra E, et al. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum Mutat. 2011 Feb;32(2):213–9.

  2. Pascual I, editor. Introducción e historia. Epidemiología: Prevalencia. In: Neurofibromatosis. Madrid: Escuela Libre Editorial, Fundación Once (ES); 2001. p. 13–9. Spanish.

  3. Pasmant E, Vidaud M, Vidaud D, Wolkenstein P. Neurofibromatosis type 1: from genotype to phenotype. J Med Genet [Internet]. 2012 Aug [cited 2014 Jan 6];49(8):483–9. Available from: http://jmg.bmj.com/content/49/8/483.full.pdf+html

  4. Espósito M, Marotta R, Roccella M, Gallai B, Parisi L, Lavano SM, et al. Pediatric neurofibromatosis 1 and parental stress: a multicenter study. Neuropsychiatr Dis Treat. [Internet]. 2014 Jan 22 [cited 2014 Jan 6];10:141–6. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904813/pdf/ndt-10-141.pdf

  5. Hsueh YP. From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation. J Biomed Sci [Internet]. 2012 Mar 26 [cited 2014 Jan 6];19:3. Available from: http://www.jbiomedsci.com/content/pdf/1423-0127-19-33.pdf

  6. Ferner RE. Neurofibromatosis 1. Eur J Hum Gent [Internet]. 2007 Feb [cited 2014 Jan 6];15(2):131–8. Available from: http://www.nature.com/ejhg/journal/vaop/ncurrent/full/5201676a.html

  7. Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol [Internet]. 2011 May [cited 2014 Jan 6];178(5):1932–9. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081157/pdf/main.pdf

  8. Online Mendelian Inheritance in Men [Internet]. Maryland: John Hopkins University (US); c1966–2014. Neurofibromatosis, Type I; 2013 [updated 2014 Jul 16; cited 2014 Jan 6]; [about 6 screens]. Available from: http://omim.org/entry/162200

  9. Medline Plus [Internet]. Washington, DC: National Library of Medicine (US); c2014. Neurofibromatosis-1; 2012 [updated 2014 Feb 3; cited 2014 Jan 10]; [about 3 p.]. Available from: http://www.nlm.nih.gov/medlineplus/spanish/neurofibromatosis.html

  10. Jiménez PE, López F, Portilla JC, Romero RM, Fermín JA, Casado I. Manifestaciones clínicas y neurorradiológicas en los adultos con neurofibromatosis tipo 1. Rev Neurol [Internet]. 2013 Jul–Aug [cited 2014 Jan 6];28(6):361–5. Available from: http://ac.els-cdn.com/S2173580813001028/1-s2.0-S2173580813001028-main.pdf?_tid=16b09d8a-9811-11e3-85f8-00000aab0f6b&acdnat=1392668671_4377a56b825cf586cc9bc236f3ad3f3c. Spanish.

  11. Pascual I, Pascual SI. Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum. Childs Nerv Syst [Internet]. 2012 Dec [cited 2014 Jan 6];28(12):2177–80. Available from: http://download.springer.com/static/pdf/165/art%253A10.1007%252Fs00381-012-1903-9.pdf?auth66=1393085479_1491348da5fabe525024ec5472568648&ext=.pdf

  12. Pérez J. Apuntes sobre la historia de la Neurofibromatosis tipo I (enfermedad de Von Recklinghausen). Piel [Internet]. 2006 Jan [cited 2014 Jan 6];21(1):[about 5 p.]. Available from: http://www.elsevier.es/es/revistas/piel-21/apuntes-historia-neurofibromatosis-tipo-i-enfermedad-von-13083553-historia-2006. Spanish.

  13. Ji J, Shimony J, Gao F, McKinstry RC, Gutmann DH. Optic nerve tortuosity in children with neurofibromatosis type 1. Pediatr Radiol [Internet]. 2013 Oct [cited 2014 Jan 6]; 43(10):1336–43. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904184/

  14. Sharif S, Upadhyaya M, Ferner R, Majounie E, Shenton A, Baser M, et al. A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype–phenotype correlations. J Med Genet [Internet]. 2011 Apr [cited 2014 Jan 6];48(4):256–60. Available from: http://jmg.bmj.com/content/48/4/256.full.pdf+html

  15. Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, et al. Visual outcomes in children with neurofibromatosis type 1–associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol [Internet]. 2012 Jun [cited 2014 Jan 6];14(6):[about 8 p.]. Available from: http://neuro-oncology.oxfordjournals.org/content/14/6/790.full.pdf+html

  16. Vogt J, Kohlhase J, Morlot S, Kluwe L, Mautner VF, Cooper DV, et al. Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation. Hum Mutat [Internet]. 2011 Jun [cited 2014 Jan 6];32(6):E2134–47. Available from: http://onlinelibrary.wiley.com/doi/10.1002/humu.21476/pdf

  17. Pascual I, Pascual SI, Velázquez R, Viaño J. Tumor del cuerpo calloso como presentación de neurofibromatosis tipo 1 en un paciente y revisión de la bibliografía. Rev Neurol [Internet]. 2012 Nov 1 [cited 2014 Jan 6];55(9):528–32. Available from: http://www.neurologia.com/pdf/Web/5509/bi090528.pdf. Spanish.

  18. Gabriele AL, Ruggieri M, Patitucci A, Magariello A, Conforti FL, Mazzei R, et al. A novel gene mutation in an italian family with neurofibromatosis type 1. Childs Nervs Syst. 2011 Apr;27(4):635–8.

  19. Secchi NC, Jiménez D. Manifestaciones neurológicas y crisis epilépticas secundarias a neurofibromatosis. Reporte de un caso. Med Int Mex [Internet]. 2011 [cited 2014 Jan 6];27(5):479–84. Available from:http://www.medigraphic.com/pdfs/medintmex/mim-2011/mim115k.pdf. Spanish.

  20. Sahin M. Neurocutaneous Syndromes. In: Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Saunders Elsevier; 2011. p. 589.

  21. Fazii P, Passamonti M, Lappa G, Di Mascio R, Ballone E. Prevalence of neurofibromatosis type 1 among the young adult population of central Italy. Arch Dermatol [Internet]. 1998 Oct [cited 2014 Jan 6];134(10):1303–4. Available from: http://archderm.ama-assn.org/cgi/reprint/134/10/1303

  22. Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol [Internet]. 2005 Jan [cited 2014 Jan 6];141(1):71–4. Available from: http://archderm.ama-assn.org/cgi/reprint/141/1/71




2020     |     www.medigraphic.com